Corcept director plans $12.2M stock sale

CORCEPT THERAPEUTICS INC (CORT) is the issuer for which director David L. Mahoney has filed a notice of proposed sale of restricted or control securities under Rule 144.

Rhea-AI Filing Summary

CORCEPT THERAPEUTICS INC (CORT) is the issuer for which director David L. Mahoney has filed a notice of proposed sale of restricted or control securities under Rule 144. The filing covers 103,606 shares of common stock held in a trust account titled “David L Mahoney & Winnifred C Ellis TR U/A DTD 06/25/1998, W Ellis & D Mahoney TTEE,” with The Charles Schwab Corporation listed as the broker. The shares were acquired through open market purchases between 05/22/2020 and 04/12/2024, and the notice is dated 08/18/2026, indicating an intention to sell these shares on the open market on or after that date, subject to Rule 144 conditions.

Key Figures

Shares proposed for sale: 103,606 shares of common stock Proposed aggregate market value: 12,160,257.00 Acquisition period for shares: 05/22/2020 to 04/12/2024 +1 more

4 metrics

Shares proposed for sale 103,606 shares of common stock Number of CORT shares covered by the Rule 144 notice

Proposed aggregate market value 12,160,257.00 Stated value associated with the 103,606 common shares in the notice

Acquisition period for shares 05/22/2020 to 04/12/2024 Period during which the 103,606 shares were acquired via open market purchases

Notice date 08/18/2026 Date of the Form 144 notice of proposed sale

Key Terms

Rule 144, open market purchases, Form 144, common stock

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

open market purchases financial

"OPEN MARKET PURCHASES AQCUIRED BETWEEN: 5/22/20 - 4/12/24"

Open market purchases are buys of a company’s shares (or other securities) made on public exchanges at prevailing market prices rather than through private deals. For investors this matters because when a company buys back its own stock it reduces the number of shares available, which can boost per-share earnings and often signals management’s confidence; it also affects supply, demand and short-term liquidity much like someone quietly buying up items from a crowded marketplace.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

common stock financial

"144: Securities Information COMMON | THE CHARLES SCHWAB CORPORATION"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for CORCEPT THERAPEUTICS INC (CORT)?

A Form 144 indicates that an affiliate, director David L. Mahoney, has notified of a planned sale of 103,606 CORT common shares under Rule 144. It signals potential future insider share sales but does not guarantee that all shares will be sold.

How many CORCEPT THERAPEUTICS INC (CORT) shares are covered by this Form 144?

The filing covers a proposed sale of 103,606 shares of CORT common stock. These shares are held in a trust account for David L. Mahoney and Winnifred C. Ellis and were acquired via open market purchases between 2020 and 2024.

When were the CORCEPT THERAPEUTICS INC (CORT) shares acquired and when may they be sold?

The 103,606 CORT shares were acquired through open market purchases between 05/22/2020 and 04/12/2024. The notice of intent to sell is dated 08/18/2026, indicating potential sales on or after that date under Rule 144.

Who is selling CORCEPT THERAPEUTICS INC (CORT) shares in this Form 144?

The person for whose account securities are to be sold is David L. Mahoney, a director of CORT. The shares are held in a trust titled for David L. Mahoney and Winnifred C. Ellis, with The Charles Schwab Corporation as broker.

What type of transaction is planned for the CORCEPT THERAPEUTICS INC (CORT) shares?

The filing states the 103,606 CORT common shares were acquired by open market purchases and are intended to be sold through open market transactions. These sales are to be conducted pursuant to Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 10:12 AM Accepted by SEC EDGAR 08/18/2026 - 10:12 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001224091
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CORCEPT THERAPEUTICS INC
SEC File Number	000-50679
Address of Issuer	101 REDWOOD SHORES PARKWAY REDWOOD CITY CALIFORNIA 94065
Phone	650.688.8803
Name of Person for Whose Account the Securities are To Be Sold	MAHONEY DAVID L
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	103606	12160257.00	108098397	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	05/22/2020	OPEN MARKET PURCHASES AQCUIRED BETWEEN: 5/22/20 - 4/12/24	OPEN MARKET			103606	05/22/2020	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	FULL ACCOUNT TITLE: DAVID L MAHONEY & WINNIFRED C ELLIS TR U/A DTD 06/25/1998, W ELLIS & D MAHONEY TTEE
Date of Notice	08/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David L Mahoney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)